Search Clinical Pathways
Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
Guidelines for evaluating patients suspected to have exocrine pancreatic insufficiency and initiating/optimizing pancreatic enzyme replacement therapy.
Bone Density Scan (DXA) Clinical Pathway — Outpatient Specialty Care and Primary Care
The DXA scan pathway takes a step-by-step approach to determine the patient populations who may require a DXA scan to evaluate for low bone mineral density.
Penicillin Drug Allergy Clinical Pathway — All Settings
The penicillin drug allergy pathway is meant to guide providers in assessing whether patients with a reported or labeled penicillin drug allergy should avoid penicillin, remove the allergy label, or refer to an allergist for skin testing or oral drug challenge.
Thyroidectomy Calcium Management Clinical Pathway — Inpatient and Outpatient Specialty Care
Intra-operative and post-operative calcium surveillance and management for pediatric thyroidectomy patients.
Pulmonary Hypertension Screening in Patients with Bronchopulmonary Dysplasia Clinical Pathway — ICU and Inpatient
Inpatient Clinical Pathway to standardize the process to screen for pulmonary hypertension in infants with Bronchopulmonary Dysplasia (BPD). BPD remains a major source of morbidity and mortality for extremely low birth weight infants.
Central Diabetes Insipidus (DI)/Arginine Vasopressin Deficiency (AVP-D) Clinical Pathway – PICU
The PICU central diabetes insipidus pathway provides guidance for the care of patients with known or suspected central diabetes insipidus requiring ICU care.
22q11.2 Hypocalcemia Screening/Treatment Clinical Pathway — Inpatient, Outpatient Specialty Care and PICU
Peri- procedure and post-procedure calcium surveillance and management for pediatric patients with 22q11.2 diagnosis.
Emergency Department and Inpatient Mitochondrial Clinical Pathway
This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.
Management of Infants with Lymphatic Disorders Clinical Pathway — Inpatient
This pathway is to be used for infants from birth to 1 year of age, admitted to an intensive care unit, with concern for lymphatic flow disorders without history of surgical/traumatic chylothorax, congenital heart disease, or isolated lymphatic mass.
Prolonged QTc and Prevention of Torsades de Pointes Clinical Pathway — Inpatient
This pathway is intended to support providers caring for children with prolonged QTc identified on ECG. Stratifications of QTC interval measurements provide guidance for care delivery. Recommendations include escalating urgent and emergent support for medical management and continued monitoring for the goal of prevention of Torsades de Pointes.